RecruitingNot ApplicableNCT06222606
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism - a Randomized, Controlled Trial
Sponsor
Aarhus University Hospital
Enrollment
160 participants
Start Date
Jan 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age\>18 years and able to give informed consent.
- Suspicion or diagnosis of thyroid cancer.
- Planned total thyroidectomy or completion thyroidectomy.
- Normocalcemia prior to surgery.
Exclusion Criteria3
- Planned simultaneous parathyroid surgery.
- Treatment with active vitamin D analogues.
- eGFR \< 30.
Interventions
PROCEDURESurgery with autofluorescence
In the experimental group, the surgeon will use the EleVision IR camera system (Medtronic, USA) to visualize parathyroid glands during surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06222606
Related Trials
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
NCT070925141 location
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
Studies on Tumors of the Thyroid
NCT000011601 location
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
NCT065078781 location
Postoperative Hypocalcemia After Thyroidectomy
NCT074280571 location